Document Detail


The effects of levosimendan on myocardial function in ropivacaine toxicity in isolated guinea pig heart preparations.
MedLine Citation:
PMID:  17717217     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Levosimendan is a novel drug used for inotropic support in heart failure, but its efficacy in local anesthetic-induced myocardial depression is not known. Therefore, we investigated the effects of levosimendan on the negative inotropic response to ropivacaine in isolated heart preparations of guinea pigs. METHODS: Action potentials and force of contraction were studied with conventional techniques in guinea-pig papillary muscles. Heart rate, systolic pressure, the first derivative of left ventricular pressure (+dP/dt(max)), coronary flow, and PR and QRS intervals were measured in isolated constant-pressure perfused, nonrecirculating Langendorff heart preparations. Single or cumulatively increasing concentrations of levosimendan and ropivacaine were used either alone or in combination. RESULTS: In isolated papillary muscle, ropivacaine reduced force of contraction in a concentration-dependent manner. Exposure to 10 microM levosimendan in the presence of 10 muM ropivacaine almost completely reversed the negative inotropic response. Sensitivity to the positive inotropic effect of levosimendan was not altered by 10 muM ropivacaine (-logEC50 [M] = 7.03 without versus 6.9 with ropivacaine, respectively). Action potential parameters were influenced only at the highest concentration. In the Langendorff heart, levosimendan significantly reversed the ropivacaine-induced reduction in heart rate, systolic pressure, coronary flow, and +dP/dt(max) to baseline values. CONCLUSION: Levosimendan is an effective inotropic drug in ropivacaine-induced myocardial depression and levosimendan myocardial sensitivity, and efficacy was not affected by the local anesthetic. Our results suggest that the calcium-sensitizing action of levosimendan is effective in local anesthetic-induced cardiac depression.
Authors:
Sebastian N Stehr; Torsten Christ; Berit Rasche; Stefan Rasche; Erich Wettwer; Andreas Deussen; Ursula Ravens; Thea Koch; Matthias Hübler
Related Documents :
10684527 - Effects of palmitoyl carnitine on perfused heart and papillary muscle.
9564547 - Vascular endothelial dysfunction contributes to myocardial depression in ischemia-reper...
19878217 - Cisplatin compromises myocardial contractile function and mitochondrial ultrastructure:...
15580517 - Progressive loss of myocardial contractile function despite unimpaired coronary blood f...
2972187 - Determinants of primary success in elective percutaneous transluminal coronary angiopla...
3756577 - Transient myocardial ischemia: experimental echocardiographic demonstration and evaluat...
Publication Detail:
Type:  In Vitro; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Anesthesia and analgesia     Volume:  105     ISSN:  1526-7598     ISO Abbreviation:  Anesth. Analg.     Publication Date:  2007 Sep 
Date Detail:
Created Date:  2007-08-24     Completed Date:  2007-09-18     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  1310650     Medline TA:  Anesth Analg     Country:  United States    
Other Details:
Languages:  eng     Pagination:  641-7     Citation Subset:  AIM; IM    
Affiliation:
Department of Anesthesiology and Intensive Care Medicine, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany. sebastian.stehr@gmx.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Action Potentials / drug effects
Amides / toxicity*
Anesthetics, Local / toxicity*
Animals
Cardiotonic Agents / pharmacology*
Coronary Circulation / drug effects
Dose-Response Relationship, Drug
Electrocardiography
Guinea Pigs
Heart / drug effects*,  physiopathology
Heart Rate / drug effects
Hydrazones / pharmacology*
Male
Myocardial Contraction / drug effects*
Papillary Muscles / drug effects*,  physiopathology
Pyridazines / pharmacology*
Time Factors
Ventricular Function, Left / drug effects*
Ventricular Pressure / drug effects
Chemical
Reg. No./Substance:
0/Amides; 0/Anesthetics, Local; 0/Cardiotonic Agents; 0/Hydrazones; 0/Pyridazines; 131741-08-7/simendan; 84057-95-4/ropivacaine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Molecular evidence of late preconditioning after sevoflurane inhalation in healthy volunteers.
Next Document:  Sevoflurane 0.25 MAC preferentially affects higher order association areas: a functional magnetic re...